2021 Annual Meeting | S10 - Epilepsy and Clinical Neurophysiology (EEG) 2
Program Materials Program Evaluations
04:00 PM - 04:08 PM EDT | Abstract |
001 - Modulation of Resting State Networks by Antiseizure Medications in Patients With Idiopathic Generalized Epilepsy
Júlia Espinosa |
04:08 PM - 04:16 PM EDT | Abstract |
002 - Functional Connectivity for Disease Classification in Epilepsy: A Machine Learning Approach
Taha Gholipour, MD |
04:16 PM - 04:24 PM EDT | Abstract |
003 - Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction
Mohammad Tabaeizadeh Fesharaki, MD |
04:24 PM - 04:32 PM EDT | Abstract |
004 - A Unique Population Based Epilepsy Network in Ontario Enhances Epilepsy Care and the Availability of Epilepsy Surgery
O. C. Snead III, MD, FAAN |
04:32 PM - 05:00 PM EDT | Q&A |
Questions and Answers
|
No disclosure on file | |
Danielle M. Andrade, MD | Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zodiac. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke therapeutics. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. |
M. B. Westover, MD, PhD | Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities. |
Fawaz Al-Mufti, MD | Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio . |
Andrea Andrade | No disclosure on file |
Elizabeth Donner, MD, FRCPC | Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR. |
Luiz E. Betting | Dr. Betting has nothing to disclose. |
Christa B. Swisher, MD | Dr. Swisher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. |
Tadeu Fantaneanu, MD | Dr. Fantaneanu has nothing to disclose. |
Taha Gholipour, MD | Dr. Gholipour has nothing to disclose. |
O. C. Snead III, MD, FAAN | Dr. Snead has nothing to disclose. |
Sahar Zafar, MD | Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus. |
Michelle Shapiro, MD | Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. |
William D. Gaillard, MD | The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF. |
Jorge G. Burneo, MD, MSPH, FAAN | Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. |
Jessica Bloomfield, MD | Dr. Bloomfield has nothing to disclose. |
Sharon E. Whiting, MBBS, FR | Dr. Whiting has nothing to disclose. |
Hiba A. Haider, MD | Dr. Haider has received publishing royalties from a publication relating to health care. Dr. Haider has received publishing royalties from a publication relating to health care. |
Aaron F. Struck, MD | The institution of Dr. Struck has received research support from Ceribell. |
Lawrence J. Hirsch, MD, FAAN | Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. |
Júlia Espinosa | Júlia Espinosa has nothing to disclose. |
Esther Bui, MD | Dr. Bui has received publishing royalties from a publication relating to health care. |
Eric Rosenthal, MD | Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care. |
Lysa Boissé Lomax, MD | Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, Eisai, Sunovion. Dr. Boissé Lomax has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Correctional Service Canada. The institution of Dr. Boissé Lomax has received research support from UCB. |
Rajesh RamachandranNair, MD | Dr. RamachandranNair has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Canada. |
Christian Hernandez, MD | Dr. Hernandez has nothing to disclose. |
Ayman E. Hassan, MD, FAAN | Dr. Hassan has nothing to disclose. |
Safa Kaleem, MD | Dr. Kaleem has nothing to disclose. |
Jeffrey D. Kennedy, MD | Dr. Kennedy has nothing to disclose. |
Angela Wabulya, MB ChB | The institution of Dr. Wabulya has received research support from Biohaven Therapeutics, Ltd. |
Mohammad Tabaeizadeh Fesharaki, MD | Dr. Tabaeizadeh Fesharaki has nothing to disclose. |